January 2003 in “Journal of Practical Aesthetic and Plastic Surgery” This study found that intralesional Diprospan injections and high-dose intravenous methylprednisolone may be effective for treating longstanding multifocal alopecia areata, with variable hair regrowth observed among patients.
February 2026 in “Frontiers in Medicine” This case series described five patients with chronic alopecia areata who successfully maintained long-term disease control using a combination of topical immunotherapy and other treatments over 9–15 years, highlighting the approach's continued value alongside novel therapies.
July 2024 in “Medical alphabet” In this case report, a 9-year-old with alopecia areata experienced full hair regrowth after six months of oral tofacitinib, with no recurrence or significant side effects for a year post-treatment.
November 2023 in “Scientific Repository of Open Access of Portugal (RCAAP)” This study reports on a severe case of alopecia areata in a healthy eight-year-old boy, highlighting persistent hair loss over four years of treatment before full regrowth, and noting that alopecia areata might indicate the early onset of autoimmune disease symptoms.
50 citations
,
January 2016 in “Journal of the American Academy of Dermatology” This systematic review of pulse corticosteroid therapy for alopecia areata found relatively low complete response rates, but responders experienced low relapse rates, indicating potential benefits for patients with favorable prognostic factors.